This chapter explores the uses of Meta AI in various everyday tasks while also addressing the genetic factors of lipoprotein A and its link to heart disease. Additionally, it examines the collapse of a high-profile IPO, highlighting the hurdles faced by investors and the shift in strategy of a prominent hedge fund manager.